De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways

Por Zeng-Brouwers, Jinyang, Beckmann, Janet, Nastase, Madalina-Viviana, Iozzo, Renato V., Schaefer, Liliana
Publicado em 2013

Soluble biglycan as a biomarker of inflammatory renal diseases

Por Hsieh, Louise Tzung-Harn, Nastase, Madalina-Viviana, Zeng-Brouwers, Jinyang, Iozzo, Renato V., Schaefer, Liliana
Publicado em 2014

Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury

Por Moreth, Kristin, Frey, Helena, Hubo, Mario, Zeng-Brouwers, Jinyang, Nastase, Madalina-Viviana, Hsieh, Louise Tzung-Harn, Haceni, Riad, Pfeilschifter, Josef, Iozzo, Renato V., Schaefer, Liliana
Publicado em 2014

Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants

Por Hsieh, Louise Tzung-Harn, Nastase, Madalina-Viviana, Roedig, Heiko, Zeng-Brouwers, Jinyang, Poluzzi, Chiara, Schwalm, Stephanie, Fork, Christian, Tredup, Claudia, Brandes, Ralf P., Wygrecka, Malgorzata, Huwiler, Andrea, Pfeilschifter, Josef, Schaefer, Liliana
Publicado no Int J Mol Sci (2017)